Nothing to be done for a first group of the 51 families who had sued the Anglo-Swedish pharmaceutical giant AstraZeneca in London as part of a potentially million-dollar class action relating to collateral damage – sometimes fatal – attributed to the anti-Covid vaccine produced by the company : the first approved in the UK and Europe during the pandemic, after being developed by Oxford University. The lawyers of 12 of these families have in fact announced that they have given up pursuing the request for compensation for damages before the High Court of the British capital, as reported by the Daily Telegraph, faced with the concrete prospect of having their appeals rejected and having to support heavy legal costs.
The announcement came after AstraZeneca itself had admitted for the first time, in court documents cited a few days ago, the possible relationship between its vaccine and episodes of Tts-type thrombosis (with thrombocytopenia syndrome) as a “very rare side effect “. While denying legal responsibilities and taking refuge both behind the generic warnings in the information leaflet and behind the protections guaranteed in the face of the Covid emergency by the British government.
The family members who backed out defended their reasons, categorically denying that they could be branded as “conspiracy theorists” and saying they were saddened at having had to give up due to the “technical quibbles” with which both the company and the government would have shielded themselves. Not without insisting both on the legitimacy of the legal battle that others are continuing to wage – in the United Kingdom as in other countries – and on the request for transparency.
breaking latest news © Copyright ANSA